QMI
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3183
- Medical specialty
- Microbiology
- FDA definition
- An in vitro nucleic acid amplification test for the quantitation of BK virus (BKV) DNA in human samples intended for use as an aid in the management of BKV in transplant patients. In patients undergoing monitoring of BKV, serial DNA measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. Test results are intended to be read and analyzed by a qualified licensed healthcare professional in conjunction with clinical signs and symptoms and relevant laboratory findings. Test results must not be the sole basis for patient management decisions.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Alinity m BKV (K241921) | Abbott Molecular, Inc. | 2025-03-24 |
| cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit (K202215) | Roche Molecular Systems, Inc. | 2020-09-02 |
Track QMI automatically
Every clearance here is in the API, with alerts when new ones post.